🇺🇸 FDA
Patent

US 6576614

Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors

expired A61PA61P31/00

Quick answer

US patent 6576614 (Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 10 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P31/00